CDKAL1 dysfunction impairs lysine codon translation in podocytes and accelerates chronic kidney disease

Read full text Summarise with VIRAT
Authors: Hiroko Nagata, Yu Nagayoshi, Takeshi Chujo, Hitomi Kaneko, Kayo Nishiguchi, Yutaka Kakizoe, Hiroko Ijima, Korin Sakakida, Takeshi Masuda, Sumio Ohtsuki, Fan‐Yan Wei, Yukie Takahashi
+10 more Takaichi Fukuda, Hideaki Jinnouchi, Yuki Adachi, Ryosuke Yamamura, Koki Matsushita, Masataka Adachi, Hideki Yokoi, Kimitoshi Nakamura, Hitoshi Nakazato, Kazuhito Tomizawa
Cited by: 0
References: 76

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Cdk5 regulatory subunit-associated protein 1-like 1 ( Cdkal1 ) encodes a tRNA-modifying enzyme responsible for thiomethylation generating 2-methylthio- N 6 -threonylcarbamoyladenosine (ms 2 t 6 A) in the anticodon loop of tRNA Lys UUU . Genome-wide association studies have identified CDKAL1 variants as risk factors for type 2 diabetes mellitus (DM) and chronic kidney disease (CKD), but whether CKD arises independently of diabetes has remained elusive. Here, we demonstrate that CDKAL1 is required for kidney function and that its dysfunction directly promotes CKD progression independently of diabetes. Systemic and podocyte-specific Cdkal1 knockout in mice leads to CKD phenotypes in later adulthood or after increasing the burden on kidney. Cdkal1 -knockout podocytes show reduced lysine-codon translation and decreased levels of lysine-rich proteins, including such that are important for podocyte functions, accompanied by impaired cell migration. These adverse effects on podocytes could be partially reversed by overexpressing CD2AP, a lysine-rich protein. These findings extend the concept of ‘tRNA modopathy’ to kidney disease and provide mechanistic insights into how defective tRNA modification contributes to kidney disease progression.

Fields of Study & Subjects

Renal Diseases and Glomerulopathies RNA modifications and cancer RNA and protein synthesis mechanisms

Publication details

Journal / source
The EMBO Journal
Volume
45
Issue
9
Pages
3206–3229
Publication date
28 March 2026
Language
EN